Dow intends not to compete in the established market segments
but to develop specialty areas which may be required for development.
(Reimbursed in 2009, first case in the world)
(New Technology Approved in 2015, Reimbursed in 2018)
Dow Biomedica Inc., Dow Bldg., 29 Yangsan-ro, Songpa-gu, Seoul Tel +82 2 2201 3602~3 Fax +82 2 2201 2166
Copyright (C) Dow Biomedica Co. All Rights Reserved.